| 1 |
Kasiske BL,Snyder JJ,Gilbertson DT, et al. Cancer after kidney transplantation in the United States[J]. Am J Transplant, 2004, 4(6): 905-913.
|
| 2 |
张健,马麟麟,解泽林, 等. 我国肾移植术后新发恶性肿瘤总结分析[J]. 中华器官移植杂志, 2014, 35(12): 705-710.
|
| 3 |
Karczewski M,Czapiewski W,Karczewski J. Urologic de novo malignancies after kidney transplantation: a single center experience[J]. Transplant Proc, 2012, 44(5): 1293-1297.
|
| 4 |
Tremblay F,Fernandes M,Habbab F, et al. Malignancy after renal transplantation incidence and role of type of immunosuppression[J]. Ann Surg One, 2002, 9(8): 785-788.
|
| 5 |
Hope CM,Coates PT,Carroll RP. Immune profilingand cancer post transplantation[J]. World J Nephrol, 2015, 4(1): 41-56.
|
| 6 |
陈万青,郑荣寿,张思维, 等. 2012年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2016, 25(1): 1-8.
|
| 7 |
王玮,尹航,李晓北, 等. 肾移植术后并发双侧自体肾盂和输尿管移行细胞癌16例[J]. 中华器官移植杂志, 2011, 32(8): 474-476.
|
| 8 |
田野,侯海军,郭宇文, 等. 肾移植患者单侧上尿路上皮肿瘤术后对侧尿路预防性切除的必要性[J]. 北京大学学报(医学版), 2013, 45(4): 558-561.
|
| 9 |
徐小明,张岩,徐自强, 等. 肾移植受者并发恶性肿瘤34例临床分析[J/CD]. 中华移植杂志：电子版, 2012, 6(2): 97-104.
|
| 10 |
郝俊文,宋华,常征, 等. 肾移植术后恶性肿瘤39例临床分析[J]. 肿瘤研究与临床, 2012, 24(1): 38-40.
|
| 11 |
Yelken B,Caliskan Y,Ozkan O, et al. Conversion to sirolimus in renal transplant recipients: a single-center experience[J]. Artif Organs, 2010, 34(8): E230-E237.
|
| 12 |
Knoll GA,Kokolo MB,Mallick R, et al. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data[J]. BMJ, 2014, 349: g6679.
|
| 13 |
俞能旺,郝俊文,刘贞, 等. 肾移植术后并发恶性肿瘤患者应用西罗莫司的经验[J]. 中华器官移植杂志, 2015, 36(6): 373-374.
|
| 14 |
Asch WS,Bia MJ. Oncologic issues and kidney transplantation：a review of frequency, mortality, and screening[J]. Adv Chronic Kidney Dis, 2014, 21(1): 106-113.
|